Anti-C9ORF72 oligonucleotides and related methods
US12378554B2 · kind B2 · utility
0Cited by
29References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2023 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Mar 3, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/53
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure provides antisense compounds, methods, and compositions for silencing C9ORF72 transcripts. The present disclosure provides antisense compounds, methods, and compositions for the treatment, prevention, or amelioration of diseases, disorders, and conditions associated with C9ORF72 in a subject in need thereof. Also contemplated are antisense compounds and methods for the preparation of a medicament for the treatment, prevention, or amelioration of a disease, disorder, or condition associated with C9ORF72.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.